:: Test Menus ::

A COMPREHENSIVE LINE OF TESTING…
THE LATEST IN TECHNOLOGY…

DCL’s priority is to keep its clients on the cutting edge with a comprehensive line of testing that includes revolutionary new capabilities that positively impact patient care. Our constant pursuit and implementation of effective new technology enables our clients to offer the best available care to their patients. In order to continue to provide advances that truly make an impact, we must continually ask…

“How can we improve your testing capabilities?”

For a list of the wide range of tests that DCL offers, please consult our in-house test menu. You will need the free Adobe Acrobat Reader to view this file.

Clinical tests not performed at DCL are primarily referred by DCL to South Bend Medical Foundation, a regional laboratory that mirrors DCL’s customer service focus and forward-looking strategy. The South Bend Medical Foundation test menu can be found at www.sbmf.org.

Core Areas of Diagnostic Testing:

Anatomic Pathology (AP): As specialists in AP, DCL has lead the transformation from conventional Pap Smears to Liquid-Based Pap Testing.

Clinical Pathology (CP): DCL offers a comprehensive line of CP testing.

Molecular Pathology (MP): DCL currently offers MP tests specifically suited for our focus on women’s health. This is a rapidly developing area of diagnostics, which we expect to yield original testing as well as enhancements to current testing methods.

Esoteric Testing: These are certain tests that our clients may benefit from that are either uncommon or highly specialized. DCL has identified partner labs that excel in their area of specialty to perform these tests.

DCL Milestones

2008 – DCL announces a strategic partnership with Third Wave Molecular Diagnostics.
2005 – DCL begins providing on-site phlebotomy and laboratory testing services to extended care facilities.
2003 – DCL becomes the first laboratory in the United States to successfully offer a DNA-based Group B Strep prenatal test.
2003 – DCL begins offering Cystic Fibrosis DNA carrier screening for preconceptual and prenatal purposes.
2002 – DCL is the first laboratory in the Midwest region to offer Chlamydia and Gonorrhea testing directly from the Thinprep® vial.
2002 – DCL adds clinical pathology services, becoming a full-service medical laboratory.
1999 – DCL becomes one of the first to offer HPV testing directly from the Thinprep® vial.
1998 – DCL opens a satellite laboratory in Illinois serving the Greater St. Louis Region.
1997 – DCL introduces the Thinprep® PapTest™ to the Midwest.
1994 – DCL creates the Division of Pharmaceutical Studies providing anatomic and molecular pathology services necessary for clinical trials of new drugs and technologies.
1984 – DCL opens one of the first freestanding fine needle biopsy clinics in the country.